These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8658641)

  • 21. Murine graft-versus-host disease in an F1-hybrid model using IFN-gamma gene knockout donors.
    Ellison CA; Fischer JM; HayGlass KT; Gartner JG
    J Immunol; 1998 Jul; 161(2):631-40. PubMed ID: 9670937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term homing assay reveals a critical role for lymphocyte function-associated antigen-1 in the hepatic recruitment of lymphocytes in graft-versus-host disease.
    Sato T; Habtezion A; Beilhack A; Schulz S; Butcher E; Thorlacius H
    J Hepatol; 2006 Jun; 44(6):1132-40. PubMed ID: 16466827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative importance of CD4+ and CD8+ T cell repertoires in the development of acute graft-versus-host disease in a murine model of bone marrow transplantation.
    Miconnet I; de La Selle V; Bruley-Rosset M
    Bone Marrow Transplant; 1998 Mar; 21(6):583-90. PubMed ID: 9543062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Murine models of graft-versus-host disease with features of scleroderma.
    Charley MR; Deng JS
    Immunol Ser; 1989; 46():625-40. PubMed ID: 2488872
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of inducible nitric oxide synthetase during graft-versus-host disease.
    Hoffman RA; Langrehr JM; Simmons RL
    Transplant Proc; 1992 Dec; 24(6):2856. PubMed ID: 1281578
    [No Abstract]   [Full Text] [Related]  

  • 26. Induction of neonatal transplantation tolerance and lymphoproliferative disorders in mice: the role of F1 donor cells.
    Jánossy T; Baranyi L; Vizler C; Nyirati I; Végh P
    Transplant Proc; 1995 Feb; 27(1):188-90. PubMed ID: 7878968
    [No Abstract]   [Full Text] [Related]  

  • 27. Cellular requirements for the induction of insulitis in chronic graft-versus-host disease.
    Ejdus L; Djordjević J; Ostojić N; Stosić S; Lukić ML
    Transplant Proc; 1993 Oct; 25(5):2837. PubMed ID: 8105584
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies of the effect of induced immune lymphopenia. I. Enhanced effects of rabbit anti-rat lymphocyte globulin in rats tolerant to rabbit immunoglobulin G.
    Denman AM; Frenkel EP
    J Immunol; 1967 Sep; 99(3):498-507. PubMed ID: 4167593
    [No Abstract]   [Full Text] [Related]  

  • 29. [Graft-versus-host reactions: models, susceptibility to control, and clinical analogies].
    Brune K
    Schweiz Med Wochenschr; 1970 Jan; 100(2):49-58. PubMed ID: 4400853
    [No Abstract]   [Full Text] [Related]  

  • 30. Dissociation between chimerism and skin graft tolerance after neonatal injection of allogenic spleen cells.
    Donckier V; Flamand V; Abramowicz D; Goldman M
    Transplant Proc; 1998 Dec; 30(8):4018-9. PubMed ID: 9865281
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of graft cytokine expression in the tolerogenicity of neonatal skin allografts.
    Gozzo J; De Fazio S
    Transplant Proc; 1999; 31(1-2):813. PubMed ID: 10083352
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunofluorescence and elution studies in tetraparental NZB forms and is formed from CFW chimaeras and graft-versus-host diseased NZB.
    Barnes RD; Holliday J; Tuffrey M
    Immunology; 1974 Jun; 26(6):1195-206. PubMed ID: 4368790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment and pretreatment of graft-versus-host reaction by antilymphocyte serum.
    Haskovcová H; Nouza K
    Folia Biol (Praha); 1970; 16(6):397-406. PubMed ID: 4395162
    [No Abstract]   [Full Text] [Related]  

  • 34. Strain specificity in the induction of syngeneic graft-versus-host disease in mice.
    Bryson JS; Jennings CD; Caywood BE; Kaplan AM
    Transplantation; 1991 Apr; 51(4):911-3. PubMed ID: 2014553
    [No Abstract]   [Full Text] [Related]  

  • 35. Renal lesions in tetraparental NZB formed and is formed from CFW mouse chimaeras simulated in NZB by injection of CFW spleen cells.
    Tuffrey M; Holliday J; Barnes RD
    J Pathol; 1974 May; 113(1):61-7. PubMed ID: 4607012
    [No Abstract]   [Full Text] [Related]  

  • 36. Modification of the graft-versus-host syndrome by anti-lymphocyte serum treatment of the donor.
    Boak JL; Wilson RE
    Clin Exp Immunol; 1968 Oct; 3(8):795-800. PubMed ID: 5718503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modification of the graft-versus-host syndrome by anti-lymphocyte serum treatment of the host.
    Boak JL; Dagher RK; Corson JM; Wilson RE
    Clin Exp Immunol; 1968 Oct; 3(8):801-8. PubMed ID: 5718504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunosuppression through blockade of transferrin receptor: mechanisms.
    Rastellini C; Li X; Braun M; Brown M; Cicalese L; Benedetti E
    Transplant Proc; 2001; 33(7-8):3279. PubMed ID: 11750403
    [No Abstract]   [Full Text] [Related]  

  • 39. Hematological and pathological changes induced in tolerant mice by the injection of syngeneic lymphoid cells.
    Cornelius EA; Martinez C; Yunis EJ; Good RA
    Transplantation; 1968 Jan; 6(1):33-44. PubMed ID: 4866737
    [No Abstract]   [Full Text] [Related]  

  • 40. Acid sphingomyelinase deficiency does not protect from graft-versus-host disease in transplant recipients with Niemann-Pick disease.
    Tolar J; Eapen M; Orchard PJ; Blazar BR
    Blood; 2010 Jan; 115(2):434-5. PubMed ID: 20075175
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.